Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2

Conditions

Breast Neoplasms 15Carcinoma, Hepatocellular 9Stomach Neoplasms 8Rectal Neoplasms 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Neoplasms 6Neoplasm Metastasis 6Ovarian Neoplasms 5Brain Neoplasms 5Thyroid Neoplasms 4Sarcoma 4Recurrence 4Urinary Bladder Neoplasms 3Pilonidal Sinus 3Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Melanoma 3Lung Neoplasms 3Kidney Neoplasms 3Glioblastoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Peritoneal Neoplasms 2Pain, Postoperative 2Pain 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Liver Neoplasms 2Gastrointestinal Stromal Tumors 2

Interventions

Sunitinib 4Surgical Procedures, Operative 2Laparoscopy 2Dasatinib 2Biopsy, Fine-Needle 2ripretinib 1motexafin lutetium 1apatinib 1Thoracic Surgery, Video-Assisted 1Surveys and Questionnaires 1Surgical Instruments 1Quality of Life 1Psychiatric Rehabilitation 1Poly(ADP-ribose) Polymerase Inhibitors 1Liver Transplantation 1Indocyanine Green 1Imatinib Mesylate 1Fluorescein 1Endoscopic Mucosal Resection 1Early Intervention, Educational 1Cytological Techniques 1Counseling 1Clobetasol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Gastrointestinal Stromal Tumors × Surgical Procedures, Operative × Clear all
NCT03862768 2019-03-05

Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment

Shanghai Zhongshan Hospital

Phase NA Unknown
92 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01054911 2016-09-22

Evaluation of Patients With Bulky GIST Using Sunitinib

University of Alabama at Birmingham

Phase NA Terminated
5 enrolled 4 charts
GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡